Michael Grissinger - 17 Apr 2025 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
4
Filing time
21 Apr 2025, 16:11:32 UTC
Previous filing
02 Jul 2024
Next filing
09 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACET Stock Option (Right to Buy) Award $0 +70,200 $0.000000 70,200 17 Apr 2025 Common Stock 70,200 $0.5258 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares shall vest in thirty-six (36) equal monthly installments following April 17, 2025; provided, however, that all vesting shall cease if the Reporting Person resigns from the Issuer's Board of Directors or otherwise ceases to serve as a director of the Issuer.